Elevated factor VIII levels and risk of venous thrombosis.
about
Thrombophilia in patients with chronic immune thrombocytopenia.The physiological functions of iron regulatory proteins in iron homeostasis - an update.Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants.Disease risk factors identified through shared genetic architecture and electronic medical recordsComplex changes in von Willebrand factor-associated parameters are acquired during uncomplicated pregnancy.Infection and venous thromboembolism in patients undergoing colorectal surgery: what is the relationship?Genetic variations in sites of affinity between FVIII and LRP1 are not associated with high FVIII levels in venous thromboembolism.Utility of a high VWF: FVIII ratio in preventing FVIII accumulation: a study in VWF-deficient mice.Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism.Analysis of Thrombophilia Test Ordering Practices at an Academic Center: A Proposal for Appropriate Testing to Reduce Harm and Cost.Evaluation of Factor VIII as a Risk Factor in Indian Patients with DVT.High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites.Thrombophilia and arteriovenous fistula survival in ESRDPostintervention duration of anticoagulation in venous surgery.Inherited risk factors for venous thromboembolism.Susoctocog Alfa: A Review in Acquired Haemophilia A.Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery.The unexpected finding of a splenic infarction in a patient with infectious mononucleosis due to Epstein-Barr virus.Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow-up study.Elevated levels of factor VIII and subsequent risk of all-cause mortality: results from the MEGA follow-up study.Monitoring hemostasis parameters in left ventricular assist device recipients - a preliminary reportMassive exploration of perturbed conditions of the blood coagulation cascade through GPU parallelization.Dabigatran for thromboprophylaxis after robotic assisted laparoscopic prostatectomy: retrospective analysis of safety profile and effect on blood coagulation.Recurrent Thrombosis: A Case of Hereditary Thromboembolism.Elevated Factor VIII Levels Associated with Acute Graft Occlusion and Arterial and Venous Thrombosis After Off Pump CABG.Cardiovascular comorbidities are increased in U.S. patients with haemophilia A: a retrospective database analysis.Risk Factors and Treatment Strategies in Patients With Retinal Vascular Occlusions.Heparin, coumarin, protein C, antithrombin, fibrinolysis and other clotting related resistances: old and new concepts in blood coagulation.Thrombotic and Hemorrhagic Conditions Due to a Gain of Function of Coagulation Proteins: A Special Type of Clotting Disorders.Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial.In reference to Laboratory assessment of sudden sensorineural hearing loss: A case-control study.Current challenges in the diagnosis and management of patients with inherited von Willebrand 's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis.Cerebral venous thrombosis associated with thyrotoxicosis, the use of desmopressin and elevated factor VIII/von Willebrand factor.Testosterone, thrombophilia, and thrombosis.Prevalence of thrombophilia according to age at the first manifestation of venous thromboembolism: results from the MAISTHRO registry.High Factor VIII and Von Willebrand Factor Levels Are Not Risk Factors of Cryptogenic Arterial Ischemic Stroke in Thai Children.Perioperative thromboprophylaxis in Cushing's disease: What we did and what we are doing?Thrombophilia Screening: Universal, Selected, or Neither?Emerging therapies for hemophilia: controversies and unanswered questions.Disappearing Inferior Vena Cava in A Pediatric Patient with Down Syndrome and Hereditary Thrombophilia
P2860
Q33418053-64F862AF-2BE9-4D7B-8CF2-583FE6546D66Q33752116-AD6CCBDC-D645-40EC-8FE5-259EF666CE6DQ33875897-04D1340E-8B0A-45EA-92BB-6F4E6996F486Q34418291-49E9A6BB-5466-44A0-9496-4DE1188D542FQ34542190-628DC94A-41B6-4753-A679-504A02FB3B35Q35096008-AC5B83AB-0AAB-434F-A1EF-49EE1D944A5CQ35188800-5B9F2F73-BB65-4C9F-902F-35A561582E30Q35846930-C09057A2-8627-42EE-A814-DBB029113A3AQ35987865-E8468107-EE04-4626-A5DC-C965846DFF4FQ36017106-57956989-D2CB-4288-BC1D-29651880D2FDQ36059509-0B14C19C-92B1-4912-A94E-9C6C47476FD5Q36200839-2C570444-9C1E-43D3-AEEC-C70DDAF19839Q36910895-79D7951E-A1E9-4D09-B620-DD080BC53382Q38088606-68F42CF7-B32F-4B6B-B30D-5A4FB68DBBC3Q38178063-20835D67-6AC0-4B10-891D-B0BEE889D351Q38813223-7EA401C0-2EAD-4D96-AC88-427D3F4BA345Q38953180-CF463312-7615-49CE-ABA2-5C9B783B5946Q40895228-A6D10870-ADE1-4055-AC12-6FB7B9D16D6FQ41486100-01F3B06A-BEE4-4A7C-B683-AC5353DE9676Q41492090-E5ED4393-7374-42A3-BEDF-71E3F83F1EE2Q41512077-61482954-1A9D-443E-A5A7-40131E95D3CCQ42213727-F0B08A74-2B30-44E8-9B71-4889EE1135EEQ43718286-B326331F-6B36-4900-A3C8-E85B79DB014CQ44845229-7737B6DF-26FA-4A25-9C84-11B204B65751Q45752008-EE61ACEF-8A8A-4419-9487-22A53E3F5DB8Q45858535-5EADDB1B-D3A3-4CDE-A88C-237B671A177DQ46391990-47258D9F-7C5F-42A2-B96D-4E11EAE19C01Q47612100-39EDE554-3472-46B4-99C9-2109E7519EB6Q47994202-DA7E7ABC-716A-4E3D-8833-6C96FB231226Q48222833-2ECFF7AA-2ED5-438A-92F4-D80F3687094EQ48329377-4AA1E3A1-DA79-46B4-93AA-B73DD9B998F8Q48545948-EBE2F8D8-0957-4C15-93C8-22F9C4EC47EAQ48581066-E3FC504D-691B-4C85-B3F9-20904859B3B2Q51044067-41008560-5962-4CBB-B99C-4C4F04B8428AQ51772962-8B803BF3-90FF-49EA-A639-771947CB668CQ53059529-04D20005-0F46-445D-AE8C-981F41FEFCDCQ53439990-56F56FBB-C82D-41EB-B1AD-96C9F1D8301CQ53812184-1C05DA70-3D19-4884-99EF-19CCFFD22452Q54958581-51D7011B-D307-4F53-81CC-36C06DC507DCQ57094165-2C0A7DD9-7F88-46C3-877A-D08BB008320F
P2860
Elevated factor VIII levels and risk of venous thrombosis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Elevated factor VIII levels and risk of venous thrombosis.
@ast
Elevated factor VIII levels and risk of venous thrombosis.
@en
Elevated factor VIII levels and risk of venous thrombosis.
@nl
type
label
Elevated factor VIII levels and risk of venous thrombosis.
@ast
Elevated factor VIII levels and risk of venous thrombosis.
@en
Elevated factor VIII levels and risk of venous thrombosis.
@nl
prefLabel
Elevated factor VIII levels and risk of venous thrombosis.
@ast
Elevated factor VIII levels and risk of venous thrombosis.
@en
Elevated factor VIII levels and risk of venous thrombosis.
@nl
P2860
P1476
Elevated factor VIII levels and risk of venous thrombosis
@en
P2093
Orla Rawley
Owen P Smith
P2860
P304
P356
10.1111/J.1365-2141.2012.09134.X
P407
P577
2012-04-25T00:00:00Z